Skip to main navigation Skip to search Skip to main content

BPI23-011: Real-World Study of First-Line Treatment Patterns in HR+/HER2– Metastatic Breast Cancer (MBC) at a Tertiary Care Cancer Institute

Research output: Contribution to conferencePresentation

Original languageAmerican English
StatePublished - Sep 22 2023

Cite this